1. GSK aims to make 1B doses of vaccine booster for multiple COVID-19 partners — Protalix and Chiesi get close to potential Fabry disease treatment approval — AstraZeneca locks up COVID-19 vaccine supply with Oxford BioMedica deal — See more on our front page news Stay updated with the latest pharma-related coronavirus news on our new page
    Dismiss Notice
  2. Think you have witnessed fraud?Ask a Whistleblower Attorney -- a chance to discuss whistleblower-related legal issues with practicing whistleblower attorneys.
    Dismiss Notice

EyePoint

Discussion in 'Ophthalmology' started by anonymous, Aug 22, 2019 at 5:47 PM.

Tags: Add Tags
  1. anonymous

    anonymous Guest

    Can you EyePoint reps stop flooding my LinkedIn page with your lame “had a good day” posts about Dexycu. We all know your product is not what you thought it would be and are desperate by throwing these Hail Mary passes hoping social media will help with this crap product.
     

  2. anonymous

    anonymous Guest

    Oh stop! You havent sold half of what we have with your silly paradigm shift.
     
  3. anonymous

    anonymous Guest

    Guess that's why u laid on my mother in her trailer and pumped that fat brown azz. she like bigg MMike o bam ah
     
  4. anonymous

    anonymous Guest

    That gig didnt last long.....
     
  5. anonymous

    anonymous Guest

    Where is my Eyepoint rep? I was planning on prescribing 2 Dexycu this year. Doubling the amount I prescribed last year!
     
  6. anonymous

    anonymous Guest

    Just get a hold of their manager, as they have been demoted to reps. God help them. Managers couldnt sell themself out of a box.